
中东和非洲自体输血设备市场预测至 2028 年 - 按类型(产品和配件)、应用(心脏手术、骨科手术、器官移植、创伤手术等)和最终用户(医院、医院)划分的 COVID-19 影响和区域分析专科诊所和门诊手术中心)
No. of Pages: 124 | Report Code: TIPRE00018189 | Category: Life Sciences
No. of Pages: 124 | Report Code: TIPRE00018189 | Category: Life Sciences
人口老龄化和生活方式的变化导致慢性病患病率稳步上升。快速增长的中产阶级人口和城市化正在推动久坐生活方式的采用。设施的现代化减少了人们的体力活动,增加了个人、职业和社会因素的压力。关节炎、心血管疾病、乳腺癌和结肠癌、糖尿病、癫痫和癫痫发作、肥胖和口腔健康问题是发达国家老年人报告的主要慢性疾病。慢性病影响公共卫生、社会和经济。自体输血装置广泛用于各种外科手术,例如心脏手术和其他侵入性手术。癌症、心血管疾病和肾脏疾病等慢性疾病是人类死亡的主要原因。这些病症通常通过外科手术治疗,这可能会导致失血过多。将新鲜血液或自己的血液输入患者体内以维持血液水平。在输血或回输过程中使用自体输血装置。因此,随着慢性病的迅速增加,自体输血设备市场也在不断增长。
<强>中东和中东非洲自体输血设备市场细分
中东和非洲非洲自体输血设备市场根据类型、应用、最终用户和国家进行细分。市场按类型分为产品和配件。 2021年,配件细分市场占有更大的市场份额。该产品细分市场进一步细分为术中自体输血系统、术后自体输血系统和双模式自体输血系统。 2021年,术中自体输血系统领域占据最大的市场份额。中东和中东地区非洲自体输血设备市场按应用分为心脏手术、骨科手术、器官移植、创伤手术等。 2021 年,心脏手术领域占据最大的市场份额。根据最终用户,市场分为医院、专科诊所和门诊手术中心。 2021 年,医院细分市场占据最大市场份额。根据国家/地区,市场分为沙特阿拉伯、阿联酋、南非以及中东和非洲其他地区。非洲。沙特阿拉伯在 2021 年贡献了相当大的份额。
BD、Braile Biomedica、Fresenius SE 和Co. KGaA、Haemonetics Corporation、Medtronic、Redax SpA、SARSTEDT AG and Co. KG、Teleflex Incorporated 和 Zimmer Biomet 都是中东和中东地区的领先公司。非洲自体输血设备市场。
Strategic insights for Middle East and Africa Autotransfusion Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 46.03 Million |
Market Size by 2028 | US$ 57.69 Million |
Global CAGR (2021 - 2028) | 3.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East and Africa Autotransfusion Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Autotransfusion Devices Market is valued at US$ 46.03 Million in 2021, it is projected to reach US$ 57.69 Million by 2028.
As per our report Middle East and Africa Autotransfusion Devices Market, the market size is valued at US$ 46.03 Million in 2021, projecting it to reach US$ 57.69 Million by 2028. This translates to a CAGR of approximately 3.3% during the forecast period.
The Middle East and Africa Autotransfusion Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Autotransfusion Devices Market report:
The Middle East and Africa Autotransfusion Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Autotransfusion Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Autotransfusion Devices Market value chain can benefit from the information contained in a comprehensive market report.